Manuel Toledo

Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

Thaís Armangué, Marianna Spatola, Alexandru Vlagea et al. · The Lancet Neurology · 2018 · 622 citations · Full text

Autoimmune Disease, Clinical Epidemiology, Immunology +8

Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial

Michel Baulac, Felix Rosenow, Manuel Toledo et al. · The Lancet Neurology · 2016 · 160 citations

Lacosamide Monotherapy, Psychotropic Medication, Controlled-release Carbamazepine +4

Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

Vicente Villanueva, Mercedes Garcés, Francisco Javier López‐González et al. · Epilepsy Research · 2016 · 128 citations

Drug Safety, Real-world Setting, Fydata Study +10

A new clinical score for the prognosis of status epilepticus in adults

Montserrat González‐Cuevas, Estevo Santamarina, Manuel Toledo et al. · European Journal of Neurology · 2016 · 95 citations

Epilepsy in time of COVID‐19: A survey‐based study

Elena Fonseca, Manuel Quintana, Sofía Lallana et al. · Acta Neurologica Scandinavica · 2020 · 94 citations · Full text